Jodi Cook, Ph.D., is President and Chief Executive Officer of Skylark Bio, Inc. She is an operationally focused business leader with experience across public and private biotechnology and medical device organizations. She brings to Skylark a unique combination of expertise across science, clinical development, operations and commercialization in both therapeutics and device companies including gene therapy modality and hearing indications. Prior to leading Skylark, Dr. Cook was Senior Vice President, Gene Therapy Strategy at PTC Therapeutics. Before PTC, Dr. Cook served as the Chief Operating Officer of Agilis Biotherapeutics where she oversaw its sale worth over $1 billion to PTC. Earlier in her career, she served as Vice President, Clinical Research & Professional Relations at InSound Medical, a company that developed, manufactured and sold extended wear hearing devices. Dr. Cook also held the role of Director, Hearing Aid Center, and Assistant Professor at the Mayo Clinic and before that was the Director of Audiology and Business Development at Songbird Hearing, and Clinical Assistant Professor at Arizona State University.

She earned her Ph.D. from Arizona State University, a Master’s of Audiology at University of South Carolina and her Bachelor of Arts from Loyola University of Maryland. She did a fellowship at Johns Hopkins Medical School in Baltimore, Maryland. She currently serves as a Board member of Fennec Pharmaceuticals and was previously Board Chair of STRM.BIO.